|
Since joining Antigenics in 2003, Ms. Sharp has been a member of the senior management team, managing strategic planning, investor relations, and financing and acquisition transactions. Prior to this, she was director of strategic planning at Elan Corporation, plc., where she served as chief of staff to the chairman of the board during the restructuring process and drove to completion a number of strategic corporate and financial transactions. Ms. Sharp was previously a management consultant at McKinsey & Company, specializing in pharmaceuticals and medical devices. She has also worked in investment banking at Goldman, Sachs & Company, primarily in the health care field. Ms. Sharp received her BA and MBA from Harvard University. | 